Sygnature Discovery

Overview

Sygnature Discovery is a UK-based company established in 2004, specializing in research and development within the business services and healthcare sectors, particularly focusing on biotechnology and pharmaceuticals. The company employs between 501 and 1,000 staff and reported significant annual revenue. Sygnature Discovery is engaged in drug discovery initiatives, offering tailored assay development services that leverage advanced technologies to support high-throughput screening and lead optimization. Their expertise includes the generation of custom cell lines and the development of multimodal assay systems, as evidenced by their recent case study on GDF15-GFRAL drug discovery. This study highlights their capabilities in creating assays that measure key signaling events with precision, facilitating efficient screening processes. The company emphasizes the integration of custom assays into existing workflows to enhance data reliability and reproducibility, reflecting their commitment to supporting complex receptor research and advancing drug discovery efforts.

Industry